Japan Lifeline Co., Ltd. (7575.T) JPX
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In JPY
Sector
Healthcare
Industry
Medical - Devices
Employees
1304
First IPO Date
January 04, 2000
| Name | Title | Pay | Year Born |
| Keisuke Suzuki | President, Chief Executive Officer & Representative Director | 0 | 1953 |
| Tatsuya Murase | Vice President, Chief Operating Officer & Representative Director | 0 | 1973 |
| Toru Takamiya | Senior Executive Officer, Head of R&D and Production Group & Director | 0 | 1964 |
| Yoshiaki Ikei | Independent Outside Director | 0 | 1957 |
| Yumiko Hoshiba | Senior Operating Officer, General Manager of Operations Division & Director | 0 | 1962 |
| Naohiro Nakada | Senior Operating Officer & Deputy Head of Arrhythmia Business Operations Group | 0 | N/A |
| Toshihiro Miyake | Executive Officer & General Manager of RA Division | 0 | N/A |
| Takeyoshi Egawa | Director, Executive Officer, CFO & Head of Corporate Management Group | 0 | 1976 |
| KuNobuo Takahashi | Senior Operating Officer & Head of Global Business Development Group | 0 | N/A |
| Kenji Yamada | Director, Executive Officer & Head of Corporate Administration Group | 0 | 1971 |
| Takashi Ito | Executive Officer, Head of Arrhythmia Business Operations Group & Director | 0 | 1968 |
Japan Lifeline Co., Ltd. is a medical technology firm based in Japan that specializes in cardiovascular healthcare devices. Its operations encompass research, manufacturing, global procurement, and sales of these specialized medical instruments within the country. The company's diverse product range includes solutions for cardiac rhythm management, such as pacemakers, implantable cardioverter defibrillators (including subcutaneous models), cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support tools. For electrophysiology and ablation procedures, Japan Lifeline offers various electrophysiological and ablation catheters (like irrigated tip versions), endoscopic balloon ablation systems, esophageal temperature monitors, internal atrial cardioversion systems, and radio-frequency transseptal needles. Furthermore, its portfolio extends to cardiovascular and endografting products, including vascular, open, and abdominal stent-grafts. In the transvascular intervention segment, the company provides PTCA and PTA guide wires, PTCA balloon catheters, radiofrequency wires, and devices for closing atrial septal defects. Complementing these, its gastrointestinal intervention solutions encompass radiofrequency ablation systems, self-expandable colonic stents, and endoscopic guidewires. Established in 1981, Japan Lifeline Co., Ltd. maintains its headquarters in Tokyo, Japan.